日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Secondary accumulation of lyso-platelet activating factors in lysosomal storage diseases

溶酶体贮积症中溶酶体-血小板激活因子的继发性积累

Kell, Pamela; Mishra, Sonali; Gray-Edwards, Heather L; Martin, Douglas R; Gaudioso, Angel; Ledesma, María Dolores; Bongarzone, Ernesto R; Sands, Mark S; Sidransky, Ellen; Ory, Daniel S; Jiang, Xuntian

Elevated oxysterol and N-palmitoyl-O-phosphocholineserine levels in congenital disorders of glycosylation

先天性糖基化障碍中氧固醇和N-棕榈酰-O-磷酸胆碱丝氨酸水平升高

Dang Do, An N; Chang, Irene J; Jiang, Xutian; Wolfe, Lynne A; Ng, Bobby G; Lam, Christina; Schnur, Rhonda E; Allis, Katrina; Hansikova, Hana; Ondruskova, Nina; O'Connor, Shawn D; Sanchez-Valle, Amarilis; Vollo, Arve; Wang, Raymond Y; Wolfenson, Zoe; Perreault, John; Ory, Daniel S; Freeze, Hudson H; Merritt, J Lawrence; Porter, Forbes D

Enhanced Efficacy and Increased Long-Term Toxicity of CNS-Directed, AAV-Based Combination Therapy for Krabbe Disease

针对克拉伯病的中枢神经系统靶向AAV联合疗法疗效增强,但长期毒性增加

Li, Yedda; Miller, Christopher A; Shea, Lauren K; Jiang, Xuntian; Guzman, Miguel A; Chandler, Randy J; Ramakrishnan, Sai M; Smith, Stephanie N; Venditti, Charles P; Vogler, Carole A; Ory, Daniel S; Ley, Timothy J; Sands, Mark S

IP(3)R-driven increases in mitochondrial Ca(2+) promote neuronal death in NPC disease

IP(3)R驱动的线粒体Ca(2+)增加促进NPC疾病中的神经元死亡

Tiscione, Scott A; Casas, Maria; Horvath, Jonathan D; Lam, Vincent; Hino, Keiko; Ory, Daniel S; Santana, L Fernando; Simó, Sergi; Dixon, Rose E; Dickson, Eamonn J

Validation of Trifluoromethylphenyl Diazirine Cholesterol Analogues As Cholesterol Mimetics and Photolabeling Reagents

三氟甲基苯基重氮丙烯胆固醇类似物作为胆固醇模拟物和光标记试剂的验证

Krishnan, Kathiresan; Qian, Mingxing; Feltes, McKenna; Chen, Zi-Wei; Gale, Sarah; Wang, Lei; Sugasawa, Yusuke; Reichert, David E; Schaffer, Jean E; Ory, Daniel S; Evers, Alex S; Covey, Douglas F

Whole exome sequencing and functional characterization increase diagnostic yield in siblings with a 46, XY difference of sexual development (DSD)

全外显子组测序和功能表征可提高46,XY性发育差异(DSD)同胞的诊断率。

Luna, Sofia E; Wegner, Daniel J; Gale, Sarah; Yang, Ping; Hollander, Abby; St Dennis-Feezle, Lori; Nabhan, Zeina M; Ory, Daniel S; Cole, F Sessions; Wambach, Jennifer A

A phase 1/2 open label nonrandomized clinical trial of intravenous 2-hydroxypropyl-β-cyclodextrin for acute liver disease in infants with Niemann-Pick C1

一项针对患有尼曼-匹克C1型疾病的婴儿急性肝病的静脉注射2-羟丙基-β-环糊精的1/2期开放标签非随机临床试验

Reynolds, Margaret; Linneman, Laura A; Luna, Sofia; Warner, Barbara B; Turmelle, Yumirle P; Kulkarni, Sakil S; Jiang, Xuntian; Khanna, Geetika; Shinawi, Marwan; Porter, Forbes D; Ory, Daniel S; Cole, F Sessions; Dickson, Patricia I

A novel gene editing system to treat both Tay-Sachs and Sandhoff diseases.

一种用于治疗泰-萨克斯病和桑德霍夫病的新型基因编辑系统

Ou Li, Przybilla Michael J, Tăbăran Alexandru-Flaviu, Overn Paula, O'Sullivan M Gerard, Jiang Xuntian, Sidhu Rohini, Kell Pamela J, Ory Daniel S, Whitley Chester B

Alterations in plasma triglycerides and ceramides: links with cardiac function in humans with type 2 diabetes

血浆甘油三酯和神经酰胺的变化:与2型糖尿病患者心脏功能的关联

Peterson, Linda R; Jiang, Xuntian; Chen, Ling; Goldberg, Anne C; Farmer, Marsha S; Ory, Daniel S; Schaffer, Jean E

Circulating ceramide ratios and risk of vascular brain aging and dementia

循环神经酰胺比例与血管性脑老化和痴呆风险

McGrath, Emer R; Himali, Jayandra J; Xanthakis, Vanessa; Duncan, Meredith S; Schaffer, Jean E; Ory, Daniel S; Peterson, Linda R; DeCarli, Charles; Pase, Matthew P; Satizabal, Claudia L; Vasan, Ramachandran S; Beiser, Alexa S; Seshadri, Sudha